Aurobindo Pharma(AUROPHARMA)
India - HyderabadPharmaceutical
Focus: Aurobindo Pharma is a large Indian pharmaceutical manufacturer with 10,000+ employees, headquartered in Hyderabad, operating as a public company (AUROPHARMA ticker). The company specializes in generic and branded pharmaceuticals with significant scale across multiple therapeutic areas.
Funding Stage
PUBLIC
Employees
10001+
Open Jobs
0
About Aurobindo Pharma
Not HiringNo open roles listed right now. Follow Aurobindo Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
- Large, stable public company (10,000+ employees) with global reach and established market presence in generics — suggests job security and established career infrastructure
- Diversified generic portfolio across BPH, antibiotics, anticonvulsants, and cardiovascular indications reduces dependence on single asset and demonstrates operational maturity
- Active pipeline with 4 programs in clinical development (3 in Phase 3) targeting high-prevalence conditions like acne and asthma — indicates ongoing innovation despite generic focus
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
1 in 5yr
VERSACLOZ
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$22M Part DDeclining
Post-LOE
Largest revenue contributor at 14% of company revenue, but post-LOE status indicates revenue erosion as generics mature.
Help build intelligence for Aurobindo Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.